CC
Checkpoint Capital Portfolio holdings
AUM
$215M
This Quarter Return
-4.92%
1 Year Return
+27.24%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-7.2%)
Cap. Flow
-$1.31M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
98.23%
Holding
21
New
5
Increased
8
Reduced
1
Closed
7
Top Buys
| 1 |
argenx
ARGX
|
$13.3M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
$9.5M |
| 3 |
Protagonist Therapeutics
PTGX
|
$8.47M |
| 4 |
Soleno Therapeutics
SLNO
|
$7.35M |
| 5 |
Revolution Medicines
RVMD
|
$6.44M |
Top Sells
| 1 |
Phathom Pharmaceuticals
PHAT
|
$18.5M |
| 2 |
Axsome Therapeutics
AXSM
|
$14.8M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.6M |
| 4 |
Pliant Therapeutics
PLRX
|
$7.05M |
| 5 |
Trevi Therapeutics
TRVI
|
$4.47M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$42.8B
| $68.1M | 37.34% |
115,000
+22,500
| +24% | +$13.3M |
|
|
2
Rhythm Pharmaceuticals
RYTM
$7.02B
| $48.1M | 26.37% |
907,240
+179,258
| +25% | +$9.5M |
|
|
3
Revolution Medicines
RVMD
$7.31B
| $13.9M | 7.61% |
392,011
+182,011
| +87% | +$6.44M |
|
|
4
Soleno Therapeutics
SLNO
$3.62B
| $12.4M | 6.78% |
172,902
+102,875
| +147% | +$7.35M |
|
5
Disc Medicine
IRON
$2.12B
| $12.1M | 6.63% |
243,311
+58,311
| +32% | +$2.89M |
|
|
6
Protagonist Therapeutics
PTGX
$3.68B
| $8.47M | 4.65% |
+175,184
| New | +$8.47M |
|
7
Stoke Therapeutics
STOK
$1.08B
| $4.86M | 2.67% |
730,717
+425,330
| +139% | +$2.83M |
|
|
SEPN
8
Septerna, Inc. Common Stock
SEPN
$548M
| $4.78M | 2.62% |
+824,878
| New | +$4.78M |
|
9
Kymera Therapeutics
KYMR
$2.9B
| $3.74M | 2.05% |
136,605
+59,070
| +76% | +$1.62M |
|
10
TScan Therapeutics
TCRX
$99.3M
| $2.78M | 1.53% |
2,017,650
+261,663
| +15% | +$361K |
|
11
Cidara Therapeutics
CDTX
$1.6B
| $2.25M | 1.23% |
104,380
-92,569
| -47% | -$1.99M |
|
12
Corcept Therapeutics
CORT
$7.46B
| $571K | 0.31% |
+5,000
| New | +$571K |
|
13
Immunocore
IMCR
$1.62B
| $267K | 0.15% |
+9,011
| New | +$267K |
|
14
RAPT Therapeutics
RAPT
$198M
| $134K | 0.07% |
+109,830
| New | +$134K |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.46B
| – | – |
-1,004,790
| Closed | -$10.6M |
|
|
16
Axsome Therapeutics
AXSM
$6.15B
| – | – |
-174,769
| Closed | -$14.8M |
|
17
Cytokinetics
CYTK
$5.96B
| – | – |
-20,000
| Closed | -$941K |
|
|
18
Phathom Pharmaceuticals
PHAT
$850M
| – | – |
-2,274,157
| Closed | -$18.5M |
|
|
19
Pliant Therapeutics
PLRX
$102M
| – | – |
-535,494
| Closed | -$7.05M |
|
|
20
Trevi Therapeutics
TRVI
$896M
| – | – |
-1,084,135
| Closed | -$4.47M |
|
|
ATYR
21
aTyr Pharma
ATYR
$560M
| – | – |
-432,561
| Closed | -$1.57M |
|